Trademarkia Logo

Australia

AU$
CYGNAL
Cancelled: Cancelled at the request of IB

Last updated on 28 Sept 2023

Owner Info

Cygnal Therapeutics, Inc.

325 Vassar Street, Suite 2B

Cambridge MA 02139, UNITED STATES OF AMERICA

Serial Number

2116870 filed on 13 Apr 2020

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

CYGNAL

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer and immune system related diseases.

Class [042]
Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of b Read More

Mark Details


Serial Number

2116870

Registered On

13 Apr 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

11 Oct 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
28th Sept 2023Status change to Voided
27th May 2021Amendment to Amend Owner Requested
12th Jan 2021International Registration in Australia Protected correspondence sent
11th Jan 2021IP Right Registration Published
11th Jan 2021Status change to Registered/Protected
29th Oct 2020Application Accepted correspondence sent
28th Oct 2020IP Right has been Examined
28th Oct 2020IP Right Acceptance Published
28th Oct 2020Status change to Accepted
7th Sept 2020Awaiting examination